Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

Tracey L. Evans, MD

Tracey L. Evans, MD

faculty photo
Associate Professor of Clinical Medicine
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
6th Floor, South Pavilion
3400 Civic Center Blvd
Philadelphia, PA 19104-4283
Office: 215-662-6681
Fax: 215-615-5888
Education:
BA (Biology and Philosophy)
University of Delaware, Summa Cum Laude, 1992.
MD
University of Pennsylvania, 1996.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Description of Research Expertise

Thoracic Malignancies
Lung Cancer

Description of Clinical Expertise

Thoracic Malignancies
Lung Cancer

Selected Publications

TL Evans: Chemotherapy in Advanced Non-small Cell Lung Cancer: Optimal Treatment Approach for Elderly and Patients with Poor Performance Status The American Journal of Hematology/Oncology. Devera Pine (eds.). The Coding Institute 11(7): 1-5 July 2015

TL Evans, BC Cho, K Udud, JR Fischer, FA Shepherd, P Martinez, R Ramlau,KN Syrigos, L Shu, M Chadjaa, M Wolf : Cabazitaxel Versus Topotecan in Patients with Small Cell Lung Cancer with Progressive During or After First-Line Platinum-Based Chemotherapy. J Thorac Oncol in press , 2015

Martin J. Edelman, Ming T. Tan, Mary J. Fidler, Rachel E. Sanborn, Greg Otterson, Lecia V. Sequest, Tracey L. Evans, Bryan J. Schneider, Roger Keresztes, Johs S. Rogers, Jorge Antunez de Mayolo, Josephine Feliciano, Yang Yang, Michelle Medeiros, and Sara L. Zaknoen: Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Patients With Biomarker-Selected Non–Small-Cell Lung Cancer Journal of Clinical Oncology 33(2): 189-194, January 2015.

Stephen Joseph Bagley, Corey J. Langer, Charu Aggarwal, Tracey L. Evans, Evan W. Alley, Roger B. Cohen, Suhong Zhang, Lynn Werner, Ian A Blair, Alexander Steven Whitehead, Anil Vachani: Pre-treatment 5-methyltetrahydrofolate levels and response to pemetrexed in stage IV adenocarcinoma of the lung. J Clin Oncol 33: abstract 8037, 2015.

Helena Alexandra Yu, Geoffrey R. Oxnard, Alexander I. Spira, Leora Horn, Jared Weiss, Yan Feng, Howard Jack West, Giuseppe Giaccone, Tracey L. Evans, Ronan Joseph Kelly, Tanya Fleege, Srinivasu Poondru, Fei Jie, Koji Aoyama, Margaret A. Foley, Debbie Whitcomb, Anne Therese Keating, Andrew P. Krivoshik: Phase I dose escalation study of ASP8273, a mutant-selective irreversible EGFR inhibitor, in subjects with EGFR mutation positive NSCLC. J Clin Oncol 33: abstract 8083, 2015.

Saman Ahmed, Charu Aggarwal, Rosemarie Mick, Trisha M Sterlicchi, Stephan Kadauke, Christofer Gault, Roger B. Cohen, Tracey L. Evans, Joshua Bauml, Charuhas Deshpande, Drew A. Torigian, Jayaram Udupa, Corey J. Langer, Jennifer J. Morrissette: Association of TP53 mutation status with clinical outcomes stratified by sensitive and non sensitive EGFR mutation, in non-small cell lung cancer (NSCLC). J Clin Oncol 33: abstract e19076, 2015.

Preeti Sudheendra, Beth Gilbert, Dawna Gillespie, Mary Coniglio, Tracey L. Evans: Improving telephone management of patient clinical concerns. Poster presented at ASCO Quality Care Symposium, J Clin Oncol 32, 2014 (suppl 30; abstr 137) October 2014.

Bauml Joshua, Langer Corey J, Evans Tracey, Garland Sheila N, Desai Krupali, Mao Jun J: Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 22(9): 2465-72, Sep 2014.

Rangwala Reshma, Leone Robert, Chang Yunyoung C, Fecher Leslie A, Schuchter Lynn M, Kramer Amy, Tan Kay-See, Heitjan Daniel F, Rodgers Glenda, Gallagher Maryann, Piao Shengfu, Troxel Andrea B, Evans Tracey L, DeMichele Angela M, Nathanson Katherine L, O'Dwyer Peter J, Kaiser Jonathon, Pontiggia Laura, Davis Lisa E, Amaravadi Ravi K: Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy 10(8): 1369-79, Aug 2014.

Rangwala Reshma, Chang Yunyoung C, Hu Janice, Algazy Kenneth M, Evans Tracey L, Fecher Leslie A, Schuchter Lynn M, Torigian Drew A, Panosian Jeffrey T, Troxel Andrea B, Tan Kay-See, Heitjan Daniel F, DeMichele Angela M, Vaughn David J, Redlinger Maryann, Alavi Abass, Kaiser Jonathon, Pontiggia Laura, Davis Lisa E, O'Dwyer Peter J, Amaravadi Ravi K: Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy 10(8): 1391-402, Aug 2014.

back to top
Last updated: 08/18/2015
The Trustees of the University of Pennsylvania